<DOC>
	<DOCNO>NCT03056222</DOCNO>
	<brief_summary>The aim study compare acute procedure safety outcomes well long term clinical outcome 2 group patient treat HeartLightÂ® Endoscopically Guided Laser Ablation ( EGLA ) commercially available Contact Force Sensing Irrigated Radiofrequency ( RF ) Ablation Catheter plus , operator 's discretion , 3D Electroanatomical Mapping ( EAM ) treatment Paroxysmal Atrial Fibrillation ( PAF ) .</brief_summary>
	<brief_title>CardioFocus v . Contact Force Guided Pulmonary Vein Isolation Paroxysmal Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Patient must undergo previous ablation treatment PAF AF Type Diagnosed symptomatic paroxysmal atrial fibrillation ( PAF ) PAF define recurrent ( two ) episode AF terminate spontaneously less seven day , usually less 48 hour Atrial fibrillation secondary reversible cause noncardiac origin Diagnosed persistent atrial fibrillation define recurrent episode last 7 less 365 day More 4 electrical cardioversions year prior enrollment include cardioversions perform within 48 hour arrhythmia onset Documented leave atrial thrombus imaging Can remove antiarrhythmic drug reason atrial fibrillation New York Heart Association ( NYHA ) functional Class III Class IV heart failure Left ventricular ejection fraction &lt; 30 % Left atrial size &gt; 55 mm measure parasternal anteroposterior view Myocardial infarction within 60 day prior enrolment Woman childbearing potential pregnant , lactate use adequate birth control</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>